DURHAM, N.C., Nov. 15 /PRNewswire/ -- AlphaMed Press, publisher of the journal STEM CELLS(R), has named Donald G. Phinney and Miodrag Stojkovic as co-editors.
Curt I. Civin, current STEM CELLS Editor, retires after eight years of unprecedented growth in areas of the journal's most significant metrics: Impact Factor, number of pages published, and number of manuscripts submitted. During his tenure as editor-in-chief, Dr. Civin was assisted by three outgoing senior editors: Alan M. Gewirtz, Robert G. Hawley, and Margaret A. Goodell.
Martin J. Murphy, STEM CELLS' Executive Editor, expressed his appreciation to the retiring editors. "I am deeply appreciative for the cumulative 26 years of leadership that Drs. Civin, Gewirtz, Hawley and Goodell have unstintingly devoted to STEM CELLS," he said. "We are honored by the care that they devoted to the review process, a process that has been enhanced by an order of magnitude under their inspiring leadership."
In the last six years, STEM CELLS' Impact Factor has risen from 2.689 to 7.924, and the number of pages published has doubled in the last two years alone, as has the number of manuscripts submitted.
The new editors, Phinney and Stojkovic, are not new to STEM CELLS. For the past year they have served as Associate Editors with responsibility to oversee the peer review of all manuscripts. They will be supported by a team of new associate editors.
Donald G. Phinney, PhD, is Professor of Immunology and Microbiology and Associate Director for Research at Tulane's Center for Gene Therapy. Professor Phinney investigates the basic biology of mesenchymal stem cells and their potential use for treatment of chronic lung disease and disorders of the central nervous system. Studies in mice have spurred pre-clinical trials to evaluate the safety and efficacy of intracranial stem cell transplantation for the treatment of neurological sequelae resulting from lysosomal storage diseases.
Miodrag Stojkovic, PhD, is Deputy Director of Centro de Investigacion Principe Felipe and head of its Cellular Reprogramming Laboratory, Valencia, Spain. In September 2006, a team led by Professor Stojkovic announced derivation of pluripotent human embryonic stem cells (hESC) from non-viable early human embryos that had stopped their cleavage. Using surplus and donated embryos, the scientists demonstrated that these arrested embryos could be used under suitable laboratory conditions for derivation of hESC. Published in STEM CELLS, the technique may help to understand and fight debilitating diseases.
About STEM CELLS(R)
STEM CELLS(R), the international journal of cell differentiation and proliferation, publishes original articles at the leading edge of stem cell research and regenerative medicine. Beginning its 26th year of publication in 2008, STEM CELLS(R) is the first journal devoted to this fast-paced field of research. Its Impact Factor, the highest of all journals devoted to the peer reviewed publication of stem cells literature, is 7.924. For more information, please visit http://www.StemCells.com or contact:
Director of Operations and Business Development
318 Blackwell Street, Suite 260
Durham, NC 27701
|SOURCE STEM CELLS|
Copyright©2007 PR Newswire.
All rights reserved